Tollovid as Rescue Agent for Paxlovid Rebound in Acute Covid-19
Citation: A. Blumenthal and L. Morgentaler, Tollovid as Rescue Agent for Paxlovid Rebound in Acute Covid-19, ResearchGate (not peer-reviewed), 2022/08/01, 10.13140/RG.2.2.36608.92165
Key Tollovid Data: Here we outline a case of SARS-CoV-2 re-infection in a Long COVID patient treated with Paxlovid. The subject reported rebound symptoms immediately after completing a 5-day course of Paxlovid. In this case study, we outline subsequent supplementation with Tollovid, a botanical 3CL protease inhibitor immune support supplement, resulting in full resolution of acute COVID symptoms.